March 5, 2021A new ADHD medication has gained approved from the U.S. Food and Drug Administration (FDA). KemPharm’s AZSTARYS™, a once-daily methylphenidate stimulant medication previously known as KP415, has been approved by for the treatment of attention deficit hyperactivity disorder (ADHD or ADD) in individuals aged six years and older.
Read more on additudemag.com